PROGNOSTIC ROLE OF PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER

被引：0
|
作者：
Setton, Ariella Jakobson [1 ,2 ]
Levin, Gabriel [3 ]
Raban, Oded [1 ,2 ]
Sabah, Gad [1 ,2 ]
Tsoref, Daliah [4 ]
From, Anat [1 ,5 ]
Perri, Tamar [3 ]
Eitan, Ram [5 ]
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Obstet & Gynecol, Tel Aviv, Israel
[3] Hadassah Univ Hosp, Obstet & Gynecol, Jerusalem, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Dept Oncol, Rabin Med Ctr Petah Tikva, Tel Aviv, Israel
[5] Tel Aviv Univ, Dept Obstet & Gynecol, Sackler Fac Med, Tel Aviv, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷
关键词：
D O I：
10.1136/ijgc-2022-igcs.319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP228/#913
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 50 条
  • [41] Prognostic role of pathologic response and cytoreductive status at interval debulking surgery after neoadjuvant chemotherapy for advanced epithelial ovarian cancer
    Liang, Margaret I.
    Prendergast, Emily N.
    Staples, Jeanine N.
    Holschneider, Christine H.
    Cohen, Joshua G.
    Cass, Ilana
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (04) : 779 - 785
  • [42] Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy
    Gasowska-Bodnar, Agnieszka
    Bodnar, Lubomir
    Dabek, Andrzej
    Cichowicz, Marzena
    Jerzak, Malgorzata
    Cierniak, Szczepan
    Kozlowski, Wojciech
    Baranowski, Wlodzimierz
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (04) : 687 - 696
  • [43] Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer
    Kang, S. Y.
    Jung, Y. S.
    Kim, K. S.
    BREAST, 2011, 20 : S48 - S48
  • [44] The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients
    Ruiz, C
    Barros, A
    Motta, E
    Pinotti, J
    BREAST, 1997, 6 (05): : P949 - P949
  • [45] Factors Predicting Pathological Complete Response and Survival Outcomes in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
    Louis, Dhanya Mary
    Mathew, Merin
    Gutjahr, Georg
    Mp, Narmada
    Nair, Lakshmi Malavika
    Bhaskaran, Renjitha
    Kottarathil, Vijaykumar Dehannathparambil
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2025,
  • [46] Factors predicting pathological complete response in patients with localized breast cancer receiving neoadjuvant chemotherapy.
    Roy, Arya Mariam
    Attwood, Kristopher
    Gandhi, Shipra
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 165 - 165
  • [47] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [48] Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer
    Siriwan Tangjitgamol
    Jitti Hanprasertpong
    Marta Cubelli
    Claudio Zamagni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 153 - 166
  • [49] Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy
    Jani, Ina
    Lastra, Ricardo R.
    Brito, Katherine S.
    Liao, Chuanhong
    Lazo, Isabel
    Lee, Nita Karnik
    Yamada, S. Diane
    Kurnit, Katherine C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (06) : 852 - 858
  • [50] Factors associated with platinum resistance in ovarian cancer patients receiving neoadjuvant chemotherapy
    Gao, Q.
    Xingyu, L.
    Ting, H.
    Jiao, X.
    Yingjun, Z.
    Ma, G.
    Huo, Y.
    Ming, L.
    Peng, Z.
    Chi, J.
    Zeng, S.
    Yuyy, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S398 - S398
12345